This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Peter JG, Neil H, Dennis LK, et al. Migraine and other Primary Headache Disorders. Principles of Internal Medicine. New York: Mc Graw Hill, 2016; p. 2586-2598.Search in Google Scholar
Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Cephalalgia. 2013;33:289-290.Search in Google Scholar
Steiner TJ, Stovner LJ, Vos T. Migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17:4.Search in Google Scholar
Blumenfeld AM, Varon SF, Wilcox TK. HRQoL and resource use among chronic and episodic migraineures: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31:301-315.Search in Google Scholar
Headache Classification Committee of the International Headache society (IHS). The International Classification of Headache Disorders. Cephalalgia. 2013;33:629-808.Search in Google Scholar
Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157-1168.Search in Google Scholar
Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53:988-994.Search in Google Scholar
Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394-402.Search in Google Scholar
Banday MS, Wani M, Para BA, Qureshi S. Impact of trigger factors on clinical profile of migraine patients. Int J Basic Clin Pharmacol. 2020;9:1191.Search in Google Scholar
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211.Search in Google Scholar
Pooja Mohan Rao. Diagnosis and Treatment of Migraine. Journal of Clinical Outcomes Management. 2017;24:516-526.Search in Google Scholar
Diener HC, Dodick DW, Aurora SK, et al. Onabotulinumtoxin A for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804-814.Search in Google Scholar
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337-1345.Search in Google Scholar
Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. Edinburgh: SIGN; 2022. https://www.sign.ac.uk/our-guidelines/pharmacological-management-of-migraine/ (15 February 2022)Search in Google Scholar
Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010611.Search in Google Scholar
